PMID- 21052570
OWN - NLM
STAT- MEDLINE
DCOM- 20110113
LR  - 20191111
IS  - 0048-7449 (Print)
IS  - 0048-7449 (Linking)
VI  - 62
IP  - 3
DP  - 2010 Jul-Sep
TI  - [Polyarthritis flare in patient with ankylosing spondylitis treated with 
      infliximab].
PG  - 221-4
AB  - Over the last ten years, the treatment of seronegative spondyloarthropathies has 
      changed dramatically with the introduction of the anti-tumor necrosis factor 
      alpha (TNFalpha) agents. Nevertheless, there is a growing number of studies 
      describing several adverse reactions in patients treated with biological agents. 
      In the present report we describe the case of a 22-year-old male patient with 
      ankylosing spondylitis who developed a "paradoxic" adverse reaction, while 
      receiving infliximab.
FAU - Gutierrez, M
AU  - Gutierrez M
AD  - Clinica Reumatologica, Universita Politecnica delle Marche, Ospedale A. Murri, 
      Jesi (AN), Italia. dr.gmarwin@gmail.com
FAU - Becciolini, A
AU  - Becciolini A
FAU - Bertolazzi, C
AU  - Bertolazzi C
FAU - Di Geso, L
AU  - Di Geso L
FAU - Tardella, M
AU  - Tardella M
FAU - Ariani, A
AU  - Ariani A
FAU - Filippucci, E
AU  - Filippucci E
FAU - Grassi, W
AU  - Grassi W
LA  - ita
PT  - Case Reports
PT  - English Abstract
PT  - Journal Article
TT  - Poliartrite febbrile in paziente affetto da spondilite anchilosante in 
      trattamento con infliximab.
PL  - Italy
TA  - Reumatismo
JT  - Reumatismo
JID - 0401302
RN  - 0 (Antibodies, Monoclonal)
RN  - 0 (Immunosuppressive Agents)
RN  - 0 (Tumor Necrosis Factor-alpha)
RN  - B72HH48FLU (Infliximab)
RN  - YL5FZ2Y5U1 (Methotrexate)
SB  - IM
MH  - Antibodies, Monoclonal/*adverse effects/therapeutic use
MH  - Arthritis/blood/*chemically induced
MH  - Fever/chemically induced
MH  - Humans
MH  - Immunosuppressive Agents/administration & dosage/*adverse effects/therapeutic use
MH  - Infliximab
MH  - Male
MH  - Methotrexate/administration & dosage/therapeutic use
MH  - Spondylitis, Ankylosing/blood/*drug therapy
MH  - Tumor Necrosis Factor-alpha/*antagonists & inhibitors
MH  - Young Adult
EDAT- 2010/11/06 06:00
MHDA- 2011/01/14 06:00
CRDT- 2010/11/06 06:00
PHST- 2010/11/06 06:00 [entrez]
PHST- 2010/11/06 06:00 [pubmed]
PHST- 2011/01/14 06:00 [medline]
AID - 10.4081/reumatismo.2010.221 [doi]
PST - ppublish
SO  - Reumatismo. 2010 Jul-Sep;62(3):221-4. doi: 10.4081/reumatismo.2010.221.